Interview with the leader of this evaluation study, Yvonne Schallberger about her positive experiences with the BÜHLMANN fCAL® turbo assay and with the CALEX® Cap stool extraction device which has also been used successfully with the ScheBo® Pancreatic Elastase. Click here.
BÜHLMANN will be present from October 15th to 19th at the 2016 United European Gastro Week Visit us at booth #31 in Hall X2 Exhibtion Highlights: Presentation of the first Infliximab Therapeutic Drug Montioring Point-of-Care Rapid Test Presentation of the first truly random access BÜHLMANN fCAL turbo assay Oral Presentation #OP247: 18 months market experience
Social Links